| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 10-mar-2020 | Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment | Martínez-González, Loreto CSIC ORCID ; Rodríguez-Cueto, Carmen; Cabezudo, Diego; Bartolomé Robledo, Fernando CSIC ORCID; Andrés-Benito, Pol; Ferrer, Isidro; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Fernández-Ruiz, Javier; Martínez Gil, Ana CSIC ORCID ; De Lago, E. | artículo |
| openAccess | | 15-ene-2021 | Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis | Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Gonzalo-Consuegra, Claudia; Liachko, Nicole F.; Pérez, Concepción CSIC ORCID; Ramírez, David; Kraemer, Brian C.; Martín-Requero, Ángeles CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; De Lago, E.; Martínez Gil, Ana CSIC ORCID | artículo |
| openAccess | | 3-ene-2022 | TDP-43 modulation by Tau-Tubulin kinase 1 inhibitors: A new avenue for future amyotrophic lateral sclerosis therapy | Nozal, Vanesa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Gómez-Almería, Marta; Gonzalo-Consuegra, Claudia; Santana, Paula; Chaikuad, Apirat; Cuevas, Eva P. CSIC ORCID ; Knapp, Stefan; Lietha, Daniel CSIC ORCID ; Ramírez, David; Petralla, Sabrina; Monti, B.; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Palomo, Valle CSIC ORCID ; De Lago, E.; Martínez Gil, Ana CSIC ORCID | artículo |
| closedAccess |  | 2015 | The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors | Moreno-Martet, Miguel; Feliú, Ana CSIC ORCID; Espejo-Porras, F.; Mecha, Miriam CSIC ORCID; Carrillo-Salinas, F. J. CSIC ORCID; Fernández-Ruiz, Javier; Guaza, Carmen CSIC ORCID ; De Lago, E. | artículo |
| openAccess |  | 20-ago-2021 | Tideglusib, a non-ATP competitive inhibitor of GSK-3β as a drug candidate for the treatment of amyotrophic lateral sclerosis | Martínez-González, Loreto CSIC ORCID ; Gonzalo-Consuegra, Claudia; Gómez-Almería, Marta; Porras, Gracia CSIC ; De Lago, E.; Martín-Requero, Ángeles CSIC ORCID ; Martínez Gil, Ana CSIC ORCID | artículo |
